CompletedNCT04481048
N Acetylcysteine for Children With Neurofibromatosis Type 1
About this title
Read the official source — NCT04481048Medication studyAges 8–16United StatesADHD
Understand this study
Who was this study for?
Listed age limits: 8 years to 16 years.
- Listed locations
- CincinnatiSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: February 23, 2021
- Recruitment status
- Completed
- Enrollment listed in the registry
- 25
- Sponsor
- Children's Hospital Medical Center, Cincinnati
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 8 Years to 16 Years
- Official registry ID
- NCT04481048
- Official title
Show the full official title
Antioxidant Therapy With N-acetylcysteine for Motor Behavior and/or Learning in Children With Neurofibromatosis Type 1
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cincinnati
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Children's Hospital Medical Center, Cincinnati, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including N-Acetyl cysteine.
Who was this study for?
Listed age limits: 8 years to 16 years.
